HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
The present disclosure provides a compound represented by structural formula (I):or a pharmaceutically acceptable salt thereof useful for treating a cancer. La présente divulgation concerne un composé représenté par la formule structurale (I), ou un sel pharmaceutiquement acceptable de celui-ci, uti...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BRUBAKER, Jason WILSON, Kevin WILSON, Douglas DINEEN, Thomas WILLIAMS, Brett KIM, Joseph PEROLA, Emanuele OZEN, Aysegul DE SAVI, Christopher ENO, Meredith BROOIJMANS, Natasja CAMPBELL, John |
| description | The present disclosure provides a compound represented by structural formula (I):or a pharmaceutically acceptable salt thereof useful for treating a cancer.
La présente divulgation concerne un composé représenté par la formule structurale (I), ou un sel pharmaceutiquement acceptable de celui-ci, utile pour traiter un cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022271749A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022271749A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022271749A13</originalsourceid><addsrcrecordid>eNrjZLD3cA1xDfJ3jnT28XRWcHV3C1Lw9PPwdPIM8Q8KVnDzD1IIDXYFCimEeLgqhAS5Oob4uvqFKPi7KTg7-jm7BvEwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvhwfyMDIyMjc0NzE0tHQ2PiVAEAFqArHA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER</title><source>esp@cenet</source><creator>BRUBAKER, Jason ; WILSON, Kevin ; WILSON, Douglas ; DINEEN, Thomas ; WILLIAMS, Brett ; KIM, Joseph ; PEROLA, Emanuele ; OZEN, Aysegul ; DE SAVI, Christopher ; ENO, Meredith ; BROOIJMANS, Natasja ; CAMPBELL, John</creator><creatorcontrib>BRUBAKER, Jason ; WILSON, Kevin ; WILSON, Douglas ; DINEEN, Thomas ; WILLIAMS, Brett ; KIM, Joseph ; PEROLA, Emanuele ; OZEN, Aysegul ; DE SAVI, Christopher ; ENO, Meredith ; BROOIJMANS, Natasja ; CAMPBELL, John</creatorcontrib><description>The present disclosure provides a compound represented by structural formula (I):or a pharmaceutically acceptable salt thereof useful for treating a cancer.
La présente divulgation concerne un composé représenté par la formule structurale (I), ou un sel pharmaceutiquement acceptable de celui-ci, utile pour traiter un cancer.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221229&DB=EPODOC&CC=WO&NR=2022271749A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221229&DB=EPODOC&CC=WO&NR=2022271749A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BRUBAKER, Jason</creatorcontrib><creatorcontrib>WILSON, Kevin</creatorcontrib><creatorcontrib>WILSON, Douglas</creatorcontrib><creatorcontrib>DINEEN, Thomas</creatorcontrib><creatorcontrib>WILLIAMS, Brett</creatorcontrib><creatorcontrib>KIM, Joseph</creatorcontrib><creatorcontrib>PEROLA, Emanuele</creatorcontrib><creatorcontrib>OZEN, Aysegul</creatorcontrib><creatorcontrib>DE SAVI, Christopher</creatorcontrib><creatorcontrib>ENO, Meredith</creatorcontrib><creatorcontrib>BROOIJMANS, Natasja</creatorcontrib><creatorcontrib>CAMPBELL, John</creatorcontrib><title>HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER</title><description>The present disclosure provides a compound represented by structural formula (I):or a pharmaceutically acceptable salt thereof useful for treating a cancer.
La présente divulgation concerne un composé représenté par la formule structurale (I), ou un sel pharmaceutiquement acceptable de celui-ci, utile pour traiter un cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD3cA1xDfJ3jnT28XRWcHV3C1Lw9PPwdPIM8Q8KVnDzD1IIDXYFCimEeLgqhAS5Oob4uvqFKPi7KTg7-jm7BvEwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvhwfyMDIyMjc0NzE0tHQ2PiVAEAFqArHA</recordid><startdate>20221229</startdate><enddate>20221229</enddate><creator>BRUBAKER, Jason</creator><creator>WILSON, Kevin</creator><creator>WILSON, Douglas</creator><creator>DINEEN, Thomas</creator><creator>WILLIAMS, Brett</creator><creator>KIM, Joseph</creator><creator>PEROLA, Emanuele</creator><creator>OZEN, Aysegul</creator><creator>DE SAVI, Christopher</creator><creator>ENO, Meredith</creator><creator>BROOIJMANS, Natasja</creator><creator>CAMPBELL, John</creator><scope>EVB</scope></search><sort><creationdate>20221229</creationdate><title>HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER</title><author>BRUBAKER, Jason ; WILSON, Kevin ; WILSON, Douglas ; DINEEN, Thomas ; WILLIAMS, Brett ; KIM, Joseph ; PEROLA, Emanuele ; OZEN, Aysegul ; DE SAVI, Christopher ; ENO, Meredith ; BROOIJMANS, Natasja ; CAMPBELL, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022271749A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BRUBAKER, Jason</creatorcontrib><creatorcontrib>WILSON, Kevin</creatorcontrib><creatorcontrib>WILSON, Douglas</creatorcontrib><creatorcontrib>DINEEN, Thomas</creatorcontrib><creatorcontrib>WILLIAMS, Brett</creatorcontrib><creatorcontrib>KIM, Joseph</creatorcontrib><creatorcontrib>PEROLA, Emanuele</creatorcontrib><creatorcontrib>OZEN, Aysegul</creatorcontrib><creatorcontrib>DE SAVI, Christopher</creatorcontrib><creatorcontrib>ENO, Meredith</creatorcontrib><creatorcontrib>BROOIJMANS, Natasja</creatorcontrib><creatorcontrib>CAMPBELL, John</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BRUBAKER, Jason</au><au>WILSON, Kevin</au><au>WILSON, Douglas</au><au>DINEEN, Thomas</au><au>WILLIAMS, Brett</au><au>KIM, Joseph</au><au>PEROLA, Emanuele</au><au>OZEN, Aysegul</au><au>DE SAVI, Christopher</au><au>ENO, Meredith</au><au>BROOIJMANS, Natasja</au><au>CAMPBELL, John</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER</title><date>2022-12-29</date><risdate>2022</risdate><abstract>The present disclosure provides a compound represented by structural formula (I):or a pharmaceutically acceptable salt thereof useful for treating a cancer.
La présente divulgation concerne un composé représenté par la formule structurale (I), ou un sel pharmaceutiquement acceptable de celui-ci, utile pour traiter un cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022271749A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A15%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BRUBAKER,%20Jason&rft.date=2022-12-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022271749A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |